发明名称 3-(Pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives and their use as 5-HT4 ligands
摘要 Compounds corresponding to the general formula (I)in which R1 represents hydrogen or an alkyl or cycloalkylmethyl group, X1 represents hydrogen or a halogen or an alkoxy group, or alternatively OR1 and X1 together represent a group of formula -OCH2O-, -O(CH2)2-, -O(CH2)3-, -O(CH2)2O- or -O(CH2)3O-, X2 represents hydrogen, an amino group or a group of general formula -NHCO2R in which R represents an alkyl or phenylalkyl group, X3 represents hydrogen or a halogen, and R2 represents hydrogen or an alkyl, phenylalkyl or [(4-dimethylamino)piperid-1-ylcarbonyl]alkyl group. Therapeutic application.
申请公布号 US6248757(B1) 申请公布日期 2001.06.19
申请号 US19990403779 申请日期 1999.11.04
申请人 SANOFI-SYNTHELABO 发明人 LOCHEAD ALISTAIR;JEGHAM SAMIR;JEUNESSE JEAN
分类号 A61K31/4245;A61K31/454;A61P1/00;A61P13/00;A61P25/00;A61P43/00;C07D413/04;C07D413/14;(IPC1-7):A61K31/445;A61K31/41;C07D413/06;C07D271/10 主分类号 A61K31/4245
代理机构 代理人
主权项
地址